Key Takeaways from 2025 Pharmaceutical Compliance Congress
General Counsel, outside counsel, compliance executives, representatives of regulatory bodies and forensic practitioners met to discuss an array of issues at the 2025 Pharmaceutical Compliance Congress. The following highlights a few burgeoning topics. Trends in Life Sciences Enforcement Enforcement of non-US anti-bribery regulations is active amidst the pause on Foreign Corrupt Practices Act enforcement. Continued…